Clinical trial
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women…
NCT00439244 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00439244 |
|---|---|
| Title | Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis |
| Official title | A One-year Partial Double-blinded, Randomized, Multi-center, Multi-national Study to Assess the Effects of Combination Therapy of Annual Zoledronic Acid (5 mg) and Daily Subcutaneous Teriparatide (2mcrg) on Postmenopausal Women With Severe Osteoporosis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Zoledronic acid, Placebo, Teriparatide |
| Enrollment | 412 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 23, 2007 |
| Last update posted | Apr 20, 2011 |
| Countries | Belgium, Germany, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: